M.Liik Comments on Kevin Freeman Smith Departure
From: David baron
Sent: Tue November 13, 2012 19:33
To: 'Michael Liik'
Cc: 'dkleebaum'
Subject: RE: Kevin Freeman Smith, VP of Business Development Leaves Cymat
Michael
Unfortunately the real growth engine for Cymat is not Alusion; it may at some point keep the companies head just above water but it is not enough to make it survive on the TSX big board. Alusion, like any design product, is an ongoing fight with every competitors for that next project, when it’s built you need to find a new project, when the economy is depressed so are your sales and based on the last few years things aren’t going to improve for some time to come.
Cymat needs to ignite opportunities in military, blast mitigation, automotive and other segments turning them into significant recurring revenue streams. The real dream for Cymat was never Alusion it only evolved as a baseline product to support the bigger vision, but who’s working on those dreams now? All shareholders see every other year are new faces starting over, learning the business, rebuilding relationships, initiating their own strategies / plans.
Many partnerships, deals, product development cycles with players such as Georg Fischer, Otokar, Bravo Zulu, Precision Technologies Ltd, Maher Limited, and many unnamed secretive companies who are testing and prototyping Cymat's technology in many ways, such as those outlined in "CYMAT ANNOUNCES NEW VALIDATION AND PROGRESS FOR ITS MILITARY PRODUCTS (February 8, 2012), over the past twelve or more years have not resulted in any measurable revenues, even though they have commercialize Cymat’s technology into their product, the heck with any recurring revenue streams.
As you know I’ve been a long-term shareholder and have seen many people come and go but the ongoing three steps forward and two back is far from encouraging. I’ve been invested in Cymat much too long and for too much to just walk away at this point at $0.03 a share because in reality that’s almost zero anyways. The only question lefts is will either of use live long enough to see any real success happen at Cymat as reflected in its share price?
Regards Dave
From: Michael Liik [mailto:mliik@liikfamholdings.com]
Sent: Tue November 13, 2012 09:01
To: 'David baron'
Subject: RE: Kevin Freeman Smith, VP of Business Development Leaves Cymat
Hi David,
The departure of Kevin is in line with our efforts to streamline overheads at Cymat. Angie, our National Accounts person has taken over Kevin’s responsibilities and has ample qualifications to lead our efforts in Alusion. As a long term shareholder, I would think that you would be pleased to see the accelerated efforts taken to get us to profitability and avoid further dilution.
Regards,
Michael
From: David baron [mailto:david.baron@sympatico.ca]
Sent: November-12-12 5:34 PM
To: 'Michael Liik'
Cc: 'dkleebaum'; dfowler@cymat.com
Subject: Kevin Freeman Smith, VP of Business Development Leaves Cymat
Michael
What other news is Cymat holding back from shareholders?
More discouraging news - Kevin Freeman Smith, VP of Business Development has also left Cymat ...
https://www.linkedin.com/profile/view?id=40406614&snapshotID=98454867&authType=name&authToken=UZ5S&trk=EML_nus_prof-FBackfillKafkaConsumer&ut=2hJjJR1syMZ5s1